In a groundbreaking collaboration, the Center for Excellence in Brain Science and Intelligence Technology at the Chinese Academy of Sciences, alongside Huashan Hospital of Fudan University and industry partners, has successfully launched China's first prospective clinical trial for invasive brain-computer interfaces (BCI). This achievement positions China as the second nation globally to advance this technology into the clinical trial phase. The subject of this trial is a male individual who lost his limbs in a high-voltage accident. Remarkably, after just 2-3 weeks of post-surgical training, he was able to engage in chess and racing games through the BCI system.

This innovative system is built upon the world's smallest and most flexible neural electrodes and implants, developed by the Center for Excellence in Brain Science and Intelligence. Utilizing minimally invasive neurosurgery, these implants achieve precision positioning and integration, paving the way for advanced functionalities. Looking ahead, this technology has the potential to extend its control capabilities to robotic arms, intelligent agents, and a host of other devices, heralding a new era in human-machine interaction.